1. investment objective: under the premise of effectively controlling portfolio risk and maintaining good liquidity, focus on investing in high-quality listed companies related to pharmaceutical innovation themes; Strive to achieve long-term stable appreciation of fund assets.
2. Performance benchmark: the yield of CSI Medical Health Index *65%+ the yield of CSI Hong Kong Stock Connect Composite Index (RMB) *20%+ the yield of SSE government bond index * 15%.
3. Risk-return characteristics: The Fund is a stock fund. Generally speaking, its long-term average risk and expected return are higher than those of bond funds, money market funds and hybrid funds. The Fund can invest in Hong Kong Stock Connect stocks. In addition to general investment risks such as market fluctuation risks similar to those of domestic securities investment funds, the Fund also faces special investment risks such as exchange rate risks and Hong Kong market risks.
1. The investment scope of the Fund includes domestic stocks issued and listed according to law, stocks listed on the Hong Kong Stock Exchange within the scope of the interconnection mechanism between the mainland and Hong Kong stock markets, bonds, asset-backed securities, bond repurchase bank deposits, interbank deposit certificates, money market instruments, financial derivatives and other financial instruments permitted by the China Securities Regulatory Commission, but it must comply with the relevant regulations of the China Securities Regulatory Commission. The proportion of the fund's investment portfolio is: the proportion of the fund's stock investment in the fund's assets ranges from 80% to 95% (the proportion of investment in Hong Kong Stock Connect stocks shall not exceed 50% of the stock assets).
2. The proportion of the fund's investment in securities with the theme of medical innovation in non-cash fund assets is not less than 80%. At the end of each trading day, after deducting the trading margin required for treasury bonds futures, stock index futures and stock option contracts, the Fund maintains cash of not less than 5% of the fund's net asset value or government bonds with maturity within one year. Cash does not include settlement reserve, deposit, subscription receivable, etc. If the future laws, regulations or regulatory agencies allow the Fund to invest in other varieties, the fund manager can include them in the investment scope after performing appropriate procedures.